Articling at Thomson, Rogers

Spirit, Passion, Excellence

Character, Preparation, Empathy

Advocacy, Tenacity, Reputation

Tradition, Teamwork, Family

Nexium®

THOMSON, ROGERS has been retained by a 52 year old male who alleges to have developed osteoporosis and suffered numerous fractures as a result of his use of Nexium®, which was prescribed to treat his acid reflux.

Nexium®, a prescription-strength proton pump inhibitor, is used for the treatment of heartburn, acid reflux, small intestine ulcers and inflammation of the esophagus and works by reducing acid in the stomach.

Thomson, Rogers is investigating whether Nexium® prevents calcium absorption by the body thereby causing bone deterioration and eventual fractures and whether the drug manufacturer AstraZeneca failed in their duty to be aware of such risks and/or disclose them to the public.

Medical reports from at least 2008 link the use of proton pump inhibitors, including Nexium®, to an increased risk of fractures and osteoporosis. Recently, the U.S. Food and Drug Administration issued warnings regarding prescription proton pump inhibitors, including Nexium®, suggesting that they may cause an increased risk of bone fractures. A lawsuit in the United States is already underway.

More Information

If you are a user of Nexium® and believe you may have suffered osteoporosis or increased fractures following extended ingestion of Nexium®, please contact Darcy Merkur via e-mail or through our toll-free number at 1-888-223-0448. Locally, in the Toronto area, you may call 416-868-3100.

If you would like to notify Health Canada of side effects you believe you have experienced as a result of the use of Nexium®, please call the Health Canada Adverse Reaction Reporting Centre at their toll-free number, 1-866-234-2345.